Search by Drug Name or NDC

    NDC 11673-0007-71 up and up famotidine complete 800; 10; 165 mg/1; mg/1; mg/1 Details

    up and up famotidine complete 800; 10; 165 mg/1; mg/1; mg/1

    up and up famotidine complete is a ORAL TABLET, CHEWABLE in the HUMAN OTC DRUG category. It is labeled and distributed by Target Corporation. The primary component is CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE.

    Product Information

    NDC 11673-0007
    Product ID 11673-007_331c742f-5dae-40cc-a064-5358a4494ea9
    Associated GPIs
    GCN Sequence Number 047669
    GCN Sequence Number Description famotidine/Ca carb/mag hydrox TAB CHEW 10-800-165 ORAL
    HIC3 Z2D
    HIC3 Description HISTAMINE H2-RECEPTOR INHIBITORS
    GCN 13069
    HICL Sequence Number 021332
    HICL Sequence Number Description FAMOTIDINE/CALCIUM CARBONATE/MAGNESIUM HYDROXIDE
    Brand/Generic Generic
    Proprietary Name up and up famotidine complete
    Proprietary Name Suffix n/a
    Non-Proprietary Name famotidine, calcium carbonate and magnesium hydroxide
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, CHEWABLE
    Route ORAL
    Active Ingredient Strength 800; 10; 165
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE
    Labeler Name Target Corporation
    Pharmaceutical Class Calculi Dissolution Agent [EPC], Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Elect
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA077355
    Listing Certified Through 2024-12-31

    Package

    NDC 11673-0007-71 (11673000771)

    NDC Package Code 11673-007-71
    Billing NDC 11673000771
    Package 50 TABLET, CHEWABLE in 1 BOTTLE (11673-007-71)
    Marketing Start Date 2015-04-27
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 70f3a4ef-3393-432c-a84d-1446ea5fa53a Details

    Revised: 7/2022